Monopar Therapeutics shares outstanding MNPR

Diluted shares outstanding, averaged over each quarter, from 2017.

Monopar Therapeutics had 2.5M diluted shares outstanding on average in Q1 FY22, the quarter to Mar 31, 2022.

That is 3.8% more than a year earlier, so each share owns a little less of the company.

Shares outstanding over time

Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.

Quarter	Ended	Shares outstanding	On a year earlier
Q1 FY22	Mar 31, 2022	2.5M	+4%
Q4 FY21	Dec 31, 2021	2.5M	+10%
Q3 FY21	Sep 30, 2021	2.5M	+13%
Q2 FY21	Jun 30, 2021	2.5M	+18%
Q1 FY21	Mar 31, 2021	2.4M	+14%
Q4 FY20	Dec 31, 2020	2.3M	+22%
Q3 FY20	Sep 30, 2020	2.2M	+20%
Q2 FY20	Jun 30, 2020	2.1M	+15%
Q1 FY20	Mar 31, 2020	2.1M	+14%
Q4 FY19	Dec 31, 2019	1.9M	+1%
Q3 FY19	Sep 30, 2019	1.9M	+0%
Q2 FY19	Jun 30, 2019	1.9M	+0%

Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.

A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.